[go: up one dir, main page]

PE20251892A1 - Composicion farmaceutica sinergica y estable de un aine y un analgesico opioide para el dolor e inflamacion - Google Patents

Composicion farmaceutica sinergica y estable de un aine y un analgesico opioide para el dolor e inflamacion

Info

Publication number
PE20251892A1
PE20251892A1 PE2024002975A PE2024002975A PE20251892A1 PE 20251892 A1 PE20251892 A1 PE 20251892A1 PE 2024002975 A PE2024002975 A PE 2024002975A PE 2024002975 A PE2024002975 A PE 2024002975A PE 20251892 A1 PE20251892 A1 PE 20251892A1
Authority
PE
Peru
Prior art keywords
pain
pharmaceutical composition
synergical
nsaid
inflammation
Prior art date
Application number
PE2024002975A
Other languages
English (en)
Inventor
Canudas Jorge Alejandro Gonzales
Olivares Marco Antonio Espinosa
Martinez Cecilia Jannette Munoz
Rubio Paola Yazmin Ollervides
Padilla Jose Guillermo Sander
Original Assignee
Laboratorios Silanes S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Silanes S A De C V filed Critical Laboratorios Silanes S A De C V
Publication of PE20251892A1 publication Critical patent/PE20251892A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se refiere a composiciones farmaceuticas que comprenden etoricoxib y tramadol, o una sal farmaceuticamente aceptable de los mismos, para el tratamiento de dolor y efecto analgesico. Tambien se trata de un proceso para la fabricacion de la composicion farmaceutica, dicha composicion comprende tramadol en una cantidad efectiva de 50 mg y etoricoxib en una cantidad efectiva de 90 mg, en donde la composicion es un granulado para reconstituir.
PE2024002975A 2024-01-12 2024-12-17 Composicion farmaceutica sinergica y estable de un aine y un analgesico opioide para el dolor e inflamacion PE20251892A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2024000705 2024-01-12

Publications (1)

Publication Number Publication Date
PE20251892A1 true PE20251892A1 (es) 2025-07-25

Family

ID=94128438

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2024002975A PE20251892A1 (es) 2024-01-12 2024-12-17 Composicion farmaceutica sinergica y estable de un aine y un analgesico opioide para el dolor e inflamacion

Country Status (8)

Country Link
US (1) US20250228797A1 (es)
EP (1) EP4585207A1 (es)
JP (1) JP2025109674A (es)
KR (1) KR20250110715A (es)
CA (1) CA3260087A1 (es)
CO (1) CO2024017757A1 (es)
DO (1) DOP2024000272A (es)
PE (1) PE20251892A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080026054A1 (en) 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
MX2016006464A (es) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
MX2017009660A (es) 2017-07-26 2017-11-23 Laboratorios Liomont S A De C V Composicion farmaceutica con un rango de relacion entre el clorhidrato de tramadol y el etoricoxib para su administracion para el tratamiento del dolor.
WO2019130049A1 (en) 2017-12-29 2019-07-04 Grünenthal GmbH Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain
MX2019008577A (es) 2019-07-18 2019-10-08 Laboratorios Liomont S A De C V Composicion farmaceutica de liberacion dual independiente que comprende un derivado del acido pirazolil bencensulfonico y un opioide de accion central con afinidad al receptor mu.

Also Published As

Publication number Publication date
EP4585207A1 (en) 2025-07-16
CO2024017757A1 (es) 2025-06-26
JP2025109674A (ja) 2025-07-25
DOP2024000272A (es) 2025-07-15
CA3260087A1 (en) 2025-11-29
KR20250110715A (ko) 2025-07-21
US20250228797A1 (en) 2025-07-17

Similar Documents

Publication Publication Date Title
JP2848556B2 (ja) 非ステロイド系抗炎症剤を含むせき／かぜ複合薬
JPS61151125A (ja) ジヒドロコデイン／イブプロフエン薬剤組成物及び方法
CN101588797A (zh) 带有最小化副作用包括减轻肝毒性的对乙酰氨基酚组合物
CA2377024A1 (en) Ophthalmic composition comprising ketotifen
AR057378A1 (es) Formulaciones de diclofenac y metodos para usarlas
US10391074B2 (en) Topical preparation for pain relief
JP5403935B2 (ja) 経口用の慢性疼痛予防または治療剤
Stocchi The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
AR030957A1 (es) Composiciones de analgesico y glucosamina
PE20251892A1 (es) Composicion farmaceutica sinergica y estable de un aine y un analgesico opioide para el dolor e inflamacion
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
AR132137A1 (es) Composiciones farmacéuticas y métodos para el tratamiento de trastornos metabólicos y hepáticos
AR039221A1 (es) Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas
AR041069A1 (es) Composicion de tolterodina liquida oral
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
Miwa et al. A phase I, randomized, open-label, cross-over study of the pharmacokinetics, dermal tolerability, and safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in healthy volunteers
RU2015114709A (ru) Стабильная композиция для инъекций, содержащая диклофенак и тиоколхикозид
CO2022001574A2 (es) Combinación sinérgica de s-ketorolaco y pregabalina en una composición farmacéutica para el tratamiento del dolor neuropático.
RU2002129356A (ru) Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство
ECSP034513A (es) Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
JP7229012B2 (ja) 内服用医薬組成物
JP7229013B2 (ja) 内服用医薬組成物
EA011926B1 (ru) Пероральный антидепрессивный состав, включающий ацетилсалициловую кислоту для ускорения начала действия
KR890701111A (ko) 사람의 이상지혈증의 치료방법
Pacifici Clinical Pharmacology of Celecoxib